APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biobanking

Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.

Selected research

Market Analysis & Forecast

Global Biobanking Market Analysis and Forecast 2026-2032

21 December 2025214 pages

Choose your research edition.

Industry ResearchBiobanking Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Biobanking Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Biobanking Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biobanking Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Biobanking Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.

Global Biobanking key players include Thermo Fisher, Beckman Coulter, Panasonic, etc. Global top three manufacturers hold a share over 15%.

United States is the largest market, with a share over 40%, followed by China, and Europe, both have a share about 50 percent.

Read the full market overview

In terms of product, Consumable is the largest segment, with a share about 55%. And in terms of application, the largest application is Population Biobanks, followed by Tissue Biobanks, Virtual Biobanks, etc.

Report Includes

This report presents an overview of global market for Biobanking, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biobanking, also provides the revenue of main regions and countries. Of the upcoming market potential for Biobanking, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biobanking revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biobanking market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biobanking revenue, projected growth trends, production technology, application and end-user industry.

Biobanking Segment by Company

Thermo Fisher

Beckman Coulter

Panasonic

SOL Group

Promega

Merck

Greiner Bio One

Chart Industries

Brooks Life Science

Tecan Group

QIAGEN

BD

Lifeline Scientific

Hamilton

So-Low

TTP Labtech Ltd

Biolife Solutions

DNA Genotek

Custom Biogenic Systems

LVL Technologies

BioRep

Biobanking Segment by Type

Equipment

Consumable

Biobanking Segment by Application

Virtual Biobanks

Tissue Biobanks

Population Biobanks

Biobanking Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biobanking market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biobanking and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biobanking.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biobanking in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biobanking company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biobanking revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biobanking Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Equipment Major Player Table 3. Consumable Major Player Table 4. Global Biobanking Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Virtual Biobanks Major Player Table 6. Tissue Biobanks Major Player Table 7. Population Biobanks Major Player Table 8. Biobanking Industry Trends Table 9. Biobanking Industry Drivers Table 10. Biobanking Industry Opportunities and Challenges Table 11. Biobanking Industry Restraints Table 12. Global Biobanking Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Biobanking Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Biobanking Market Share by Region (2021-2026) Table 15. Global Biobanking Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Biobanking Market Share by Region (2027-2032) Table 17. Global Biobanking Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Biobanking Revenue Market Share by Players (2021-2026) Table 19. Global Biobanking Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Biobanking Key Players Headquarters & Area Served Table 21. Global Biobanking Players, Product Type & Application Table 22. Global Biobanking Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Biobanking by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Biobanking Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Biobanking Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Biobanking Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Biobanking Revenue Market Share by Type (2021-2026) Table 29. Global Biobanking Revenue Market Share by Type (2027-2032) Table 30. Global Biobanking Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Biobanking Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Biobanking Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Biobanking Revenue Market Share by Application (2021-2026) Table 34. Global Biobanking Revenue Market Share by Application (2027-2032) Table 35. Thermo Fisher Company Information Table 36. Thermo Fisher Business Overview Table 37. Thermo Fisher Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Thermo Fisher Biobanking Product Portfolio Table 39. Thermo Fisher Recent Development Table 40. Beckman Coulter Company Information Table 41. Beckman Coulter Business Overview Table 42. Beckman Coulter Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Beckman Coulter Biobanking Product Portfolio Table 44. Beckman Coulter Recent Development Table 45. Panasonic Company Information Table 46. Panasonic Business Overview Table 47. Panasonic Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Panasonic Biobanking Product Portfolio Table 49. Panasonic Recent Development Table 50. SOL Group Company Information Table 51. SOL Group Business Overview Table 52. SOL Group Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. SOL Group Biobanking Product Portfolio Table 54. SOL Group Recent Development Table 55. Promega Company Information Table 56. Promega Business Overview Table 57. Promega Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Promega Biobanking Product Portfolio Table 59. Promega Recent Development Table 60. Merck Company Information Table 61. Merck Business Overview Table 62. Merck Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Merck Biobanking Product Portfolio Table 64. Merck Recent Development Table 65. Greiner Bio One Company Information Table 66. Greiner Bio One Business Overview Table 67. Greiner Bio One Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Greiner Bio One Biobanking Product Portfolio Table 69. Greiner Bio One Recent Development Table 70. Chart Industries Company Information Table 71. Chart Industries Business Overview Table 72. Chart Industries Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Chart Industries Biobanking Product Portfolio Table 74. Chart Industries Recent Development Table 75. Brooks Life Science Company Information Table 76. Brooks Life Science Business Overview Table 77. Brooks Life Science Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Brooks Life Science Biobanking Product Portfolio Table 79. Brooks Life Science Recent Development Table 80. Tecan Group Company Information Table 81. Tecan Group Business Overview Table 82. Tecan Group Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Tecan Group Biobanking Product Portfolio Table 84. Tecan Group Recent Development Table 85. QIAGEN Company Information Table 86. QIAGEN Business Overview Table 87. QIAGEN Biobanking Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. QIAGEN Biobanking Product Portfolio Table 89. QIAGEN Recent Development Table 90. BD Company Information Table 91. BD Business Overview Table 92. BD Biobanking Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. BD Biobanking Product Portfolio Table 94. BD Recent Development Table 95. Lifeline Scientific Company Information Table 96. Lifeline Scientific Business Overview Table 97. Lifeline Scientific Biobanking Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Lifeline Scientific Biobanking Product Portfolio Table 99. Lifeline Scientific Recent Development Table 100. Hamilton Company Information Table 101. Hamilton Business Overview Table 102. Hamilton Biobanking Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Hamilton Biobanking Product Portfolio Table 104. Hamilton Recent Development Table 105. So-Low Company Information Table 106. So-Low Business Overview Table 107. So-Low Biobanking Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. So-Low Biobanking Product Portfolio Table 109. So-Low Recent Development Table 110. TTP Labtech Ltd Company Information Table 111. TTP Labtech Ltd Business Overview Table 112. TTP Labtech Ltd Biobanking Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 113. TTP Labtech Ltd Biobanking Product Portfolio Table 114. TTP Labtech Ltd Recent Development Table 115. Biolife Solutions Company Information Table 116. Biolife Solutions Business Overview Table 117. Biolife Solutions Biobanking Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 118. Biolife Solutions Biobanking Product Portfolio Table 119. Biolife Solutions Recent Development Table 120. DNA Genotek Company Information Table 121. DNA Genotek Business Overview Table 122. DNA Genotek Biobanking Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 123. DNA Genotek Biobanking Product Portfolio Table 124. DNA Genotek Recent Development Table 125. Custom Biogenic Systems Company Information Table 126. Custom Biogenic Systems Business Overview Table 127. Custom Biogenic Systems Biobanking Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 128. Custom Biogenic Systems Biobanking Product Portfolio Table 129. Custom Biogenic Systems Recent Development Table 130. LVL Technologies Company Information Table 131. LVL Technologies Business Overview Table 132. LVL Technologies Biobanking Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 133. LVL Technologies Biobanking Product Portfolio Table 134. LVL Technologies Recent Development Table 135. BioRep Company Information Table 136. BioRep Business Overview Table 137. BioRep Biobanking Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 138. BioRep Biobanking Product Portfolio Table 139. BioRep Recent Development Table 140. North America Biobanking Revenue by Type (2021-2026) & (US$ Million) Table 141. North America Biobanking Revenue by Type (2027-2032) & (US$ Million) Table 142. North America Biobanking Revenue by Application (2021-2026) & (US$ Million) Table 143. North America Biobanking Revenue by Application (2027-2032) & (US$ Million) Table 144. North America Biobanking Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. North America Biobanking Revenue by Country (2021-2026) & (US$ Million) Table 146. North America Biobanking Revenue by Country (US$ Million) & (2027-2032) Table 147. Europe Biobanking Revenue by Type (2021-2026) & (US$ Million) Table 148. Europe Biobanking Revenue by Type (2027-2032) & (US$ Million) Table 149. Europe Biobanking Revenue by Application (2021-2026) & (US$ Million) Table 150. Europe Biobanking Revenue by Application (2027-2032) & (US$ Million) Table 151. Europe Biobanking Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Europe Biobanking Revenue by Country (2021-2026) & (US$ Million) Table 153. Europe Biobanking Revenue by Country (US$ Million) & (2027-2032) Table 154. China Biobanking Revenue by Type (2021-2026) & (US$ Million) Table 155. China Biobanking Revenue by Type (2027-2032) & (US$ Million) Table 156. China Biobanking Revenue by Application (2021-2026) & (US$ Million) Table 157. China Biobanking Revenue by Application (2027-2032) & (US$ Million) Table 158. Asia Biobanking Revenue by Type (2021-2026) & (US$ Million) Table 159. Asia Biobanking Revenue by Type (2027-2032) & (US$ Million) Table 160. Asia Biobanking Revenue by Application (2021-2026) & (US$ Million) Table 161. Asia Biobanking Revenue by Application (2027-2032) & (US$ Million) Table 162. Asia Biobanking Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 163. Asia Biobanking Revenue by Region (US$ Million) & (2021-2026) Table 164. Asia Biobanking Revenue by Region (US$ Million) & (2027-2032) Table 165. SAMEA Biobanking Revenue by Type (2021-2026) & (US$ Million) Table 166. SAMEA Biobanking Revenue by Type (2027-2032) & (US$ Million) Table 167. SAMEA Biobanking Revenue by Application (2021-2026) & (US$ Million) Table 168. SAMEA Biobanking Revenue by Application (2027-2032) & (US$ Million) Table 169. SAMEA Biobanking Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. SAMEA Biobanking Revenue by Country (2021-2026) & (US$ Million) Table 171. SAMEA Biobanking Revenue by Country (US$ Million) & (2027-2032) Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Biobanking Image Figure 2. Global Biobanking Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biobanking Market Size Share 2021 VS 2025 VS 2032 Figure 4. Equipment Image Figure 5. Consumable Image Figure 6. Global Biobanking Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Biobanking Market Size Share 2021 VS 2025 VS 2032 Figure 8. Virtual Biobanks Image Figure 9. Tissue Biobanks Image Figure 10. Population Biobanks Image Figure 11. Global Biobanking Market Size (US$ Million) & (2021-2032) Figure 12. Global Biobanking Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Biobanking Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Biobanking Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Biobanking Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Biobanking Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Biobanking Revenue Market Share by Type (2021-2032) Figure 19. Global Biobanking Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Biobanking Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Biobanking Revenue Market Share by Application (2021-2032) Figure 22. North America Biobanking Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Biobanking Revenue Share by Type (2021-2032) Figure 24. North America Biobanking Revenue Share by Application (2021-2032) Figure 25. North America Biobanking Revenue Share by Country (2021-2032) Figure 26. United States Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Biobanking Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Biobanking Revenue Share by Type (2021-2032) Figure 31. Europe Biobanking Revenue Share by Application (2021-2032) Figure 32. Europe Biobanking Revenue Share by Country (2021-2032) Figure 33. Germany Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Biobanking Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Biobanking Revenue Share by Type (2021-2032) Figure 43. China Biobanking Revenue Share by Application (2021-2032) Figure 44. Asia Biobanking Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Biobanking Revenue Share by Type (2021-2032) Figure 46. Asia Biobanking Revenue Share by Application (2021-2032) Figure 47. Asia Biobanking Revenue Share by Region (2021-2032) Figure 48. Japan Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Biobanking Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Biobanking Revenue Share by Type (2021-2032) Figure 56. SAMEA Biobanking Revenue Share by Application (2021-2032) Figure 57. SAMEA Biobanking Revenue Share by Country (2021-2032) Figure 58. Brazil Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Biobanking Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Equipment
  • Consumable
Applications
  • Virtual Biobanks
  • Tissue Biobanks
  • Population Biobanks
Companies covered
  • Thermo Fisher
  • Beckman Coulter
  • Panasonic
  • SOL Group
  • Promega
  • Merck
  • Greiner Bio One
  • Chart Industries
  • Brooks Life Science
  • Tecan Group
  • QIAGEN
  • BD
  • Lifeline Scientific
  • Hamilton
  • So-Low
  • TTP Labtech Ltd
  • Biolife Solutions
  • DNA Genotek
  • Custom Biogenic Systems
  • LVL Technologies
  • BioRep

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biobanking Market by Type
  3. 1.2.1 Global Biobanking Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Equipment
  5. 1.2.3 Consumable
  6. 1.3 Biobanking Market by Application
  7. 1.3.1 Global Biobanking Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Virtual Biobanks
  9. 1.3.3 Tissue Biobanks
  10. 1.3.4 Population Biobanks
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Biobanking Market Dynamics
  1. 2.1 Biobanking Industry Trends
  2. 2.2 Biobanking Industry Drivers
  3. 2.3 Biobanking Industry Opportunities and Challenges
  4. 2.4 Biobanking Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biobanking Market Perspective (2021-2032)
  2. 3.2 Global Biobanking Growth Trends by Region
  3. 3.2.1 Global Biobanking Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biobanking Market Size by Region (2021-2026)
  5. 3.2.3 Global Biobanking Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biobanking Revenue by Players
  2. 4.1.1 Global Biobanking Revenue by Players (2021-2026)
  3. 4.1.2 Global Biobanking Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biobanking Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biobanking Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biobanking Key Players Headquarters & Area Served
  7. 4.4 Global Biobanking Players, Product Type & Application
  8. 4.5 Global Biobanking Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biobanking Market CR5 and HHI
  11. 4.6.3 2025 Biobanking Tier 1, Tier 2, and Tier 3
5 Biobanking Market Size by Type
  1. 5.1 Global Biobanking Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biobanking Revenue by Type (2021-2032)
  3. 5.3 Global Biobanking Revenue Market Share by Type (2021-2032)
6 Biobanking Market Size by Application
  1. 6.1 Global Biobanking Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biobanking Revenue by Application (2021-2032)
  3. 6.3 Global Biobanking Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Thermo Fisher
  2. 7.1.1 Thermo Fisher Company Information
  3. 7.1.2 Thermo Fisher Business Overview
  4. 7.1.3 Thermo Fisher Biobanking Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Biobanking Product Portfolio
  6. 7.1.5 Thermo Fisher Recent Developments
  7. 7.2 Beckman Coulter
  8. 7.2.1 Beckman Coulter Company Information
  9. 7.2.2 Beckman Coulter Business Overview
  10. 7.2.3 Beckman Coulter Biobanking Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Beckman Coulter Biobanking Product Portfolio
  12. 7.2.5 Beckman Coulter Recent Developments
  13. 7.3 Panasonic
  14. 7.3.1 Panasonic Company Information
  15. 7.3.2 Panasonic Business Overview
  16. 7.3.3 Panasonic Biobanking Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Panasonic Biobanking Product Portfolio
  18. 7.3.5 Panasonic Recent Developments
  19. 7.4 SOL Group
  20. 7.4.1 SOL Group Company Information
  21. 7.4.2 SOL Group Business Overview
  22. 7.4.3 SOL Group Biobanking Revenue and Gross Margin (2021-2026)
  23. 7.4.4 SOL Group Biobanking Product Portfolio
  24. 7.4.5 SOL Group Recent Developments
  25. 7.5 Promega
  26. 7.5.1 Promega Company Information
  27. 7.5.2 Promega Business Overview
  28. 7.5.3 Promega Biobanking Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Promega Biobanking Product Portfolio
  30. 7.5.5 Promega Recent Developments
  31. 7.6 Merck
  32. 7.6.1 Merck Company Information
  33. 7.6.2 Merck Business Overview
  34. 7.6.3 Merck Biobanking Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Merck Biobanking Product Portfolio
  36. 7.6.5 Merck Recent Developments
  37. 7.7 Greiner Bio One
  38. 7.7.1 Greiner Bio One Company Information
  39. 7.7.2 Greiner Bio One Business Overview
  40. 7.7.3 Greiner Bio One Biobanking Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Greiner Bio One Biobanking Product Portfolio
  42. 7.7.5 Greiner Bio One Recent Developments
  43. 7.8 Chart Industries
  44. 7.8.1 Chart Industries Company Information
  45. 7.8.2 Chart Industries Business Overview
  46. 7.8.3 Chart Industries Biobanking Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Chart Industries Biobanking Product Portfolio
  48. 7.8.5 Chart Industries Recent Developments
  49. 7.9 Brooks Life Science
  50. 7.9.1 Brooks Life Science Company Information
  51. 7.9.2 Brooks Life Science Business Overview
  52. 7.9.3 Brooks Life Science Biobanking Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Brooks Life Science Biobanking Product Portfolio
  54. 7.9.5 Brooks Life Science Recent Developments
  55. 7.10 Tecan Group
  56. 7.10.1 Tecan Group Company Information
  57. 7.10.2 Tecan Group Business Overview
  58. 7.10.3 Tecan Group Biobanking Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Tecan Group Biobanking Product Portfolio
  60. 7.10.5 Tecan Group Recent Developments
  61. 7.11 QIAGEN
  62. 7.11.1 QIAGEN Company Information
  63. 7.11.2 QIAGEN Business Overview
  64. 7.11.3 QIAGEN Biobanking Revenue and Gross Margin (2021-2026)
  65. 7.11.4 QIAGEN Biobanking Product Portfolio
  66. 7.11.5 QIAGEN Recent Developments
  67. 7.12 BD
  68. 7.12.1 BD Company Information
  69. 7.12.2 BD Business Overview
  70. 7.12.3 BD Biobanking Revenue and Gross Margin (2021-2026)
  71. 7.12.4 BD Biobanking Product Portfolio
  72. 7.12.5 BD Recent Developments
  73. 7.13 Lifeline Scientific
  74. 7.13.1 Lifeline Scientific Company Information
  75. 7.13.2 Lifeline Scientific Business Overview
  76. 7.13.3 Lifeline Scientific Biobanking Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Lifeline Scientific Biobanking Product Portfolio
  78. 7.13.5 Lifeline Scientific Recent Developments
  79. 7.14 Hamilton
  80. 7.14.1 Hamilton Company Information
  81. 7.14.2 Hamilton Business Overview
  82. 7.14.3 Hamilton Biobanking Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Hamilton Biobanking Product Portfolio
  84. 7.14.5 Hamilton Recent Developments
  85. 7.15 So-Low
  86. 7.15.1 So-Low Company Information
  87. 7.15.2 So-Low Business Overview
  88. 7.15.3 So-Low Biobanking Revenue and Gross Margin (2021-2026)
  89. 7.15.4 So-Low Biobanking Product Portfolio
  90. 7.15.5 So-Low Recent Developments
  91. 7.16 TTP Labtech Ltd
  92. 7.16.1 TTP Labtech Ltd Company Information
  93. 7.16.2 TTP Labtech Ltd Business Overview
  94. 7.16.3 TTP Labtech Ltd Biobanking Revenue and Gross Margin (2021-2026)
  95. 7.16.4 TTP Labtech Ltd Biobanking Product Portfolio
  96. 7.16.5 TTP Labtech Ltd Recent Developments
  97. 7.17 Biolife Solutions
  98. 7.17.1 Biolife Solutions Company Information
  99. 7.17.2 Biolife Solutions Business Overview
  100. 7.17.3 Biolife Solutions Biobanking Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Biolife Solutions Biobanking Product Portfolio
  102. 7.17.5 Biolife Solutions Recent Developments
  103. 7.18 DNA Genotek
  104. 7.18.1 DNA Genotek Company Information
  105. 7.18.2 DNA Genotek Business Overview
  106. 7.18.3 DNA Genotek Biobanking Revenue and Gross Margin (2021-2026)
  107. 7.18.4 DNA Genotek Biobanking Product Portfolio
  108. 7.18.5 DNA Genotek Recent Developments
  109. 7.19 Custom Biogenic Systems
  110. 7.19.1 Custom Biogenic Systems Company Information
  111. 7.19.2 Custom Biogenic Systems Business Overview
  112. 7.19.3 Custom Biogenic Systems Biobanking Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Custom Biogenic Systems Biobanking Product Portfolio
  114. 7.19.5 Custom Biogenic Systems Recent Developments
  115. 7.20 LVL Technologies
  116. 7.20.1 LVL Technologies Company Information
  117. 7.20.2 LVL Technologies Business Overview
  118. 7.20.3 LVL Technologies Biobanking Revenue and Gross Margin (2021-2026)
  119. 7.20.4 LVL Technologies Biobanking Product Portfolio
  120. 7.20.5 LVL Technologies Recent Developments
  121. 7.21 BioRep
  122. 7.21.1 BioRep Company Information
  123. 7.21.2 BioRep Business Overview
  124. 7.21.3 BioRep Biobanking Revenue and Gross Margin (2021-2026)
  125. 7.21.4 BioRep Biobanking Product Portfolio
  126. 7.21.5 BioRep Recent Developments
8 North America
  1. 8.1 North America Biobanking Revenue (2021-2032)
  2. 8.2 North America Biobanking Revenue by Type (2021-2032)
  3. 8.2.1 North America Biobanking Revenue by Type (2021-2026)
  4. 8.2.2 North America Biobanking Revenue by Type (2027-2032)
  5. 8.3 North America Biobanking Revenue Share by Type (2021-2032)
  6. 8.4 North America Biobanking Revenue by Application (2021-2032)
  7. 8.4.1 North America Biobanking Revenue by Application (2021-2026)
  8. 8.4.2 North America Biobanking Revenue by Application (2027-2032)
  9. 8.5 North America Biobanking Revenue Share by Application (2021-2032)
  10. 8.6 North America Biobanking Revenue by Country
  11. 8.6.1 North America Biobanking Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biobanking Revenue by Country (2021-2026)
  13. 8.6.3 North America Biobanking Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Biobanking Revenue (2021-2032)
  2. 9.2 Europe Biobanking Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biobanking Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biobanking Revenue by Type (2027-2032)
  5. 9.3 Europe Biobanking Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biobanking Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biobanking Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biobanking Revenue by Application (2027-2032)
  9. 9.5 Europe Biobanking Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biobanking Revenue by Country
  11. 9.6.1 Europe Biobanking Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biobanking Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biobanking Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Biobanking Revenue (2021-2032)
  2. 10.2 China Biobanking Revenue by Type (2021-2032)
  3. 10.2.1 China Biobanking Revenue by Type (2021-2026)
  4. 10.2.2 China Biobanking Revenue by Type (2027-2032)
  5. 10.3 China Biobanking Revenue Share by Type (2021-2032)
  6. 10.4 China Biobanking Revenue by Application (2021-2032)
  7. 10.4.1 China Biobanking Revenue by Application (2021-2026)
  8. 10.4.2 China Biobanking Revenue by Application (2027-2032)
  9. 10.5 China Biobanking Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biobanking Revenue (2021-2032)
  2. 11.2 Asia Biobanking Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biobanking Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biobanking Revenue by Type (2027-2032)
  5. 11.3 Asia Biobanking Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biobanking Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biobanking Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biobanking Revenue by Application (2027-2032)
  9. 11.5 Asia Biobanking Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biobanking Revenue by Country
  11. 11.6.1 Asia Biobanking Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biobanking Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biobanking Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biobanking Revenue (2021-2032)
  2. 12.2 SAMEA Biobanking Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biobanking Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biobanking Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biobanking Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biobanking Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biobanking Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biobanking Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biobanking Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biobanking Revenue by Country
  11. 12.6.1 SAMEA Biobanking Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biobanking Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biobanking Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst